UnitedHealth Group (NYSE:UNH) Trading Up 1.1%

UnitedHealth Group Incorporated (NYSE:UNHGet Free Report)’s share price traded up 1.1% during trading on Tuesday . The stock traded as high as $504.99 and last traded at $502.69. 781,020 shares changed hands during trading, a decline of 81% from the average session volume of 4,175,794 shares. The stock had previously closed at $497.44.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of analyst reports. Piper Sandler lifted their price objective on UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a report on Wednesday, April 17th. Bank of America reaffirmed a “buy” rating and set a $675.00 price target on shares of UnitedHealth Group in a report on Thursday, March 7th. Truist Financial restated a “buy” rating and issued a $600.00 target price on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Baird R W upgraded shares of UnitedHealth Group to a “strong-buy” rating in a research report on Thursday, May 30th. Finally, Robert W. Baird began coverage on shares of UnitedHealth Group in a research report on Thursday, May 30th. They set an “outperform” rating and a $597.00 target price on the stock. Three equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $578.75.

Check Out Our Latest Analysis on UnitedHealth Group

UnitedHealth Group Stock Performance

The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.85 and a current ratio of 0.85. The stock has a market cap of $463.21 billion, a P/E ratio of 30.76, a PEG ratio of 1.47 and a beta of 0.58. The stock has a fifty day simple moving average of $490.29 and a 200-day simple moving average of $508.39.

UnitedHealth Group (NYSE:UNHGet Free Report) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The firm had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. During the same period in the previous year, the business earned $6.26 EPS. The company’s revenue was up 8.6% compared to the same quarter last year. On average, equities analysts expect that UnitedHealth Group Incorporated will post 27.57 earnings per share for the current year.

Insiders Place Their Bets

In other news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Insiders own 0.33% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in UNH. Texas Capital Bancshares Inc TX grew its holdings in UnitedHealth Group by 1.1% in the third quarter. Texas Capital Bancshares Inc TX now owns 1,695 shares of the healthcare conglomerate’s stock worth $855,000 after purchasing an additional 19 shares during the period. Tealwood Asset Management Inc. increased its holdings in shares of UnitedHealth Group by 0.4% during the fourth quarter. Tealwood Asset Management Inc. now owns 4,988 shares of the healthcare conglomerate’s stock valued at $2,626,000 after acquiring an additional 19 shares in the last quarter. Atlas Private Wealth Advisors grew its position in UnitedHealth Group by 1.1% in the 4th quarter. Atlas Private Wealth Advisors now owns 1,752 shares of the healthcare conglomerate’s stock valued at $923,000 after purchasing an additional 19 shares during the period. Prentice Wealth Management LLC increased its position in shares of UnitedHealth Group by 0.8% during the fourth quarter. Prentice Wealth Management LLC now owns 2,347 shares of the healthcare conglomerate’s stock worth $1,235,000 after acquiring an additional 19 shares in the last quarter. Finally, Baker Avenue Asset Management LP boosted its stake in UnitedHealth Group by 1.7% during the 3rd quarter. Baker Avenue Asset Management LP now owns 1,219 shares of the healthcare conglomerate’s stock valued at $615,000 after purchasing an additional 20 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Company Profile

(Get Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.